Reuters logo
BRIEF-EQL Pharma: Zonisamid EQL Pharma approved in Denmark
October 10, 2016 / 2:32 PM / a year ago

BRIEF-EQL Pharma: Zonisamid EQL Pharma approved in Denmark

Oct 10 (Reuters) - EQL Pharma AB :

* Medical product Zonisamid EQL Pharma has been approved for sale by the Danish Medicines Agency

* Total turnover of the original product in Denmark is about 12 million Swedish crowns ($1.39 million) annually

* Aims to start selling Zonisamid EQL Pharma in Q1 2017 at the latest

Source text: bit.ly/2dFKRVl

Further company coverage:

$1 = 8.6231 Swedish crowns Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below